Evaluation of Effect of TRC101 on Progression of Chronic Kidney Disease in Subjects With Metabolic Acidosis
Status:
Recruiting
Trial end date:
2024-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effect of TRC101 on the progression of chronic
kidney disease (CKD) and to evaluate the safety profile of TRC101 in CKD patients with
metabolic acidosis.